# Faeth Therapeutics, Inc.: Form DEF 14A, filed Apr 28, 2022

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: DEF 14A
- Filed: 2022-04-28
- Accepted by EDGAR: Apr 28, 2022, 16:13 ET
- Period: 2022-06-10
- Accession: 0001193125-22-127574
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312522127574/d258546ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312522127574/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312522127574/d258546ddef14a.htm

Filed Apr 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-127574. Last ingested by Listed: Nov 14, 2026, 19:01 ET. No prices; not investment advice.
